National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage ↓	Form	Price
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	431,309 L.L
M01AH05	ETOXIB	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,126,140 L.L
N06DA03	EXELON TRANSDERMAL PATCH 10	B	Rivastigmine - 9.5mg/24h	9.5mg/24h	Patch	2,457,888 L.L
C01CA03	EPINORD	G	Noradrenaline (tartrate) - 8mg/4ml	8mg/4ml	Injectable solution	2,751,678 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 80mg	80mg	Tablet	2,023,827 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 8000U Anti-Xa/0.8ml	8000U Anti-Xa/0.8ml	Injectable solution	1,025,160 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 8000IU Anti-XA/0.8ml	8000IU Anti-XA/0.8ml	Injectable solution	963,535 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 8000IU Anti-XA/0.8ml	8000IU Anti-XA/0.8ml	Injectable solution	4,575,784 L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 8,000U Anti-Xa/0.8ml	8,000U Anti-Xa/0.8ml	Injectable solution	963,535 L.L
N06AX16	EFEXOR XR	B	Venlafaxine (HCl) - 75mg	75mg	Capsule, sustained release	732,394 L.L
L01EA02	ELPIDA	G	Dasatinib - 70mg	70mg	Tablet, film coated	127,364,905 L.L
G03XC01	EVA TABLET	G	Raloxifene HCl - 60mg	60mg	Tablet	1,354,081 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
M01AH05	ETOXA	G	Etoricoxib - 60mg	60mg	Tablet, film coated	904,854 L.L
M01AH05	ETOXA	G	Etoricoxib - 60mg	60mg	Tablet, film coated	302,045 L.L
M01AH05	ETOXIB	G	Etoricoxib - 60mg	60mg	Tablet, film coated	694,767 L.L
B01AB05	ENOXAPARIN LEDRAXEN	BioTech	Enoxaparin sodium - 6000UI (60mg)/0.6ml	6000UI (60mg)/0.6ml	Injectable solution	854,684 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 6000U Anti-Xa/0.6ml	6000U Anti-Xa/0.6ml	Injectable solution	922,772 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 6000IU Anti-XA/0.6ml	6000IU Anti-XA/0.6ml	Injectable solution	765,990 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 6000IU Anti-XA/0.6ml	6000IU Anti-XA/0.6ml	Injectable solution	3,637,782 L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 6,000U Anti-Xa/0.6ml	6,000U Anti-Xa/0.6ml	Injectable solution	765,990 L.L
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 6 Billions/2g	6 billions/2g	Powder for suspension	1,493,009 L.L
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 6 Billions/2g	6 billions/2g	Powder for suspension	1,343,843 L.L
L04AX04	ERVALI	G	Lenalidomide - 5mg	5mg	Capsule, hard	37,370,561 L.L
B01AF02	ELIQUIS	B	Apixaban - 5mg	5mg	Tablet, film coated	4,183,603 L.L
B01AF02	ELAPIX 5	G	Apixaban - 5mg	5mg	Tablet, film coated	1,970,969 L.L
G04BE08	ENKOR	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 5mg	5mg	Tablet	73,160,279 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 5mg	5mg	Tablet	89,386,347 L.L

...